Detalhe da pesquisa
1.
M2-Deficient Single-Replication Influenza Vaccine-Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain.
J Infect Dis
; 226(1): 83-90, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34323977
2.
Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults.
J Infect Dis
; 227(1): 103-112, 2022 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36350017
3.
Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge.
Vaccine
; 42(11): 2770-2780, 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508930
4.
Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge.
Vaccines (Basel)
; 11(4)2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37112710
5.
Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants.
Vaccines (Basel)
; 11(6)2023 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37376452
6.
Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice.
Vaccines (Basel)
; 10(12)2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36560540
7.
Influenza A virus infection-induced macroautophagy facilitates MHC class II-restricted endogenous presentation of an immunodominant viral epitope.
FEBS J
; 288(10): 3164-3185, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830641
8.
Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults.
Vaccines (Basel)
; 9(12)2021 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34960134
9.
Monocyte apoptotic bodies are vehicles for influenza A virus propagation.
Commun Biol
; 3(1): 223, 2020 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385344
10.
Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.
Vaccine
; 37(32): 4533-4542, 2019 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31280945
11.
Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
Vaccine
; 36(33): 5097-5103, 2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30007825
12.
M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
Vaccine
; 35(33): 4177-4183, 2017 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28668565
13.
M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice.
Vaccine
; 34(42): 5090-5098, 2016 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27595896
14.
An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus.
Vaccine
; 29(12): 2308-12, 2011 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-21272601
15.
Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice.
Vaccine
; 28(3): 664-72, 2010 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-19895924
16.
Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus.
Hum Immunol
; 71(5): 468-74, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20156506
17.
Rationally engineered therapeutic proteins with reduced immunogenicity.
J Immunol
; 174(6): 3187-96, 2005 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15749848